Sponsored By
Litigation
FDA building.jpg
Supplement Regulations
FDA says ingredient studied as drug—β-NMN—is excluded from supplementsFDA says ingredient studied as drug—β-NMN—is excluded from supplements
FDA’s recently held position is likely to cause disruption to the NMN marketplace and may culminate in a fight—perhaps litigation—between the dietary supplement and drug industries, with the public health agency at the center of the dispute.
.png?width=700&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale "Amazon resumes sales of NAC supplements")
Recommended
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.